Lesson plan
Affinity maturation
In immunology, affinity maturation is the process by which T FH cell-activated B cells produce antibodies with increased affinity for antigen during the course of an immune response. With repeated exposures to the same antigen, a host will produce antibodies of successively greater affinities. A secondary response can elicit antibodies with several fold greater affinity than in a primary response. Affinity maturation primarily occurs on membrane immunoglobulin of germinal center B cells and as a direct result of somatic hypermutation (SHM) and selection by T FH cells. Affinity maturation also occurs when GC B cells encounter antigens related to the original antigen they were raised against, as long as some binding capabilities remain against the new variant antigen. Over many rounds of maturation against new variants, GC B cells could (very rarely) end up producing broadly-neutralizing antibodies that bind the common (conserved) part of these antigens. One ideal in the field of vaccination is to reliably replicate this process so as to immunize against a broad spectrum of related pathogens. __TOC__
Article summary
In immunology, affinity maturation is the process by which T FH cell-activated B cells produce antibodies with increased affinity for antigen during the course of an immune response. With repeated exposures to the same antigen, a host will produce antibodies of successively greater affinities. A secondary response can elicit antibodies with several fold greater affinity than in a primary response. Affinity maturation primarily occurs on membrane immunoglobulin of germinal center B cells and as a direct result of somatic hypermutation (SHM) and selection by T FH cells. Affinity maturation also occurs when GC B cells encounter antigens related to the original antigen they were raised against, as long as some binding capabilities remain against the new variant antigen. Over many rounds of maturation against new variants, GC B cells could (very rarely) end up producing broadly-neutralizing antibodies that bind the common (conserved) part of these antigens. One ideal in the field of vaccination is to reliably replicate this process so as to immunize against a broad spectrum of related pathogens. __TOC__
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.